Drugs / E-cigarette
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03209661 Comparator | Apr 2017 → Aug 2018 | arteriosclerosis disorder | University of Texas at Austin | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E-cigarette | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03209661 ↗ |
| Route | Inhaled | “Subjects will be asked to inhale an E-Cigarette with 5.4% NBV for 6 min.” NCT03209661 ↗ |